173 related articles for article (PubMed ID: 6188011)
1. Further advances in the management of malignant teratomas of the testis and other sites.
Newlands ES; Begent RH; Rustin GJ; Parker D; Bagshawe KD
Lancet; 1983 Apr; 1(8331):948-51. PubMed ID: 6188011
[TBL] [Abstract][Full Text] [Related]
2. Current optimum management of anaplastic germ cell tumours of the testis and other sites.
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Crawford SM; Holden L
Br J Urol; 1986 Jun; 58(3):307-14. PubMed ID: 2424538
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patients with poor prognosis anaplastic germ cell tumours (AGCT) of the testis and other sites.
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Crawford SM; Holden L
Int J Androl; 1987 Feb; 10(1):301-9. PubMed ID: 2438223
[TBL] [Abstract][Full Text] [Related]
4. Prognosis following chemotherapy for metastatic malignant teratoma.
Horwich A; Easton D; Husband J; Nicholas D; Peckham MJ
Br J Urol; 1987 Jun; 59(6):578-83. PubMed ID: 2446691
[TBL] [Abstract][Full Text] [Related]
5. Treatment of disseminated germ cell tumours of the testis.
Athanassiou A; Pectasides D; Bafaloukos D; Barbounis V; Dimitriadis M; Christodoulou K
Br J Urol; 1989 May; 63(5):525-30. PubMed ID: 2471573
[TBL] [Abstract][Full Text] [Related]
6. Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
Mazumdar M; Bajorin DF; Bacik J; Higgins G; Motzer RJ; Bosl GJ
J Clin Oncol; 2001 May; 19(9):2534-41. PubMed ID: 11331333
[TBL] [Abstract][Full Text] [Related]
7. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
Newlands ES
Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
[TBL] [Abstract][Full Text] [Related]
8. alpha-Fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) demonstrated in the immature glands of mediastinal teratocarcinoma: a case report.
Irie T; Watanabe H; Kawaoi A; Takeuchi J
Cancer; 1982 Sep; 50(6):1160-5. PubMed ID: 6179592
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy in the treatment of germ cell tumors containing choriocarcinoma in males and females.
Goldstein DP; Piro AJ
Surg Gynecol Obstet; 1972 Jan; 134(1):61-6. PubMed ID: 4332022
[No Abstract] [Full Text] [Related]
10. POMB/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity.
Husband DJ; Green JA
Eur J Cancer; 1992; 28(1):86-91. PubMed ID: 1373636
[TBL] [Abstract][Full Text] [Related]
11. Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours.
Horwich A; Brada M; Nicholls J; Jay G; Hendry WF; Dearnaley D; Peckham MJ
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):177-84. PubMed ID: 2467806
[TBL] [Abstract][Full Text] [Related]
12. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
Gerl A; Lamerz R; Clemm C; Mann K; Hartenstein R; Wilmanns W
Clin Cancer Res; 1996 Sep; 2(9):1565-70. PubMed ID: 9816334
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
Stevens MJ; Norman AR; Dearnaley DP; Horwich A
J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin combination chemotherapy in the management of testicular neoplasia.
Samuels ML; Holoye PY; Johnson DE
Cancer; 1975 Aug; 36(2):318-26. PubMed ID: 50869
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling.
Kollmannsberger C; Nichols C; Meisner C; Mayer F; Kanz L; Bokemeyer C
Ann Oncol; 2000 Sep; 11(9):1115-20. PubMed ID: 11061604
[TBL] [Abstract][Full Text] [Related]
16. Tumour-marker levels and prognosis in malignant teratoma of the testis.
Germa-Lluch JR; Begent RH; Bagshawe KD
Br J Cancer; 1980 Dec; 42(6):850-5. PubMed ID: 6161630
[TBL] [Abstract][Full Text] [Related]
17. [Case report of a non-seminomatous testicular neoplasm indicating marked efficacy of a combination chemotherapy of VBL, ACTD, BLM, CDDP and EX (VAB-4 combination therapy)].
Hayashi M; Ebihara K; Urano E
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2775-7. PubMed ID: 6210063
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin combination chemotherapy for advanced germ-cell testicular tumours.
Taylor RE; Duncan W; Davey P; Munro AJ; Cornbleet MA
Br J Urol; 1985 Oct; 57(5):567-73. PubMed ID: 2415203
[TBL] [Abstract][Full Text] [Related]
19. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
[TBL] [Abstract][Full Text] [Related]
20. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Skinner DG; Scardino PT
Trans Am Assoc Genitourin Surg; 1979; 71():31-5. PubMed ID: 94715
[No Abstract] [Full Text] [Related]
[Next] [New Search]
